Drug Shortage Report for DILANTIN-125 SUSPENSION
| Report ID | 151037 |
| Drug Identification Number | 00023450 |
| Brand name | DILANTIN-125 SUSPENSION |
| Common or Proper name | Dilantin |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | PHENYTOIN |
| Strength(s) | 125MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | ORAL ORAL |
| Packaging size | Oral Suspension 250ml |
| ATC code | N03AB |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2021-12-23 |
| Actual start date | 2022-01-07 |
| Estimated end date | 2022-04-01 |
| Actual end date | 2022-03-31 |
| Shortage status | Resolved |
| Updated date | 2022-04-01 |
| Company comments | One lot with an expiry date of June/30/2022 remains available in stock |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v17 | 2022-04-01 | English | Compare |
| v16 | 2022-03-31 | French | Compare |
| v15 | 2022-03-31 | English | Compare |
| v14 | 2022-03-24 | French | Compare |
| v13 | 2022-03-24 | English | Compare |
| v12 | 2022-03-22 | French | Compare |
| v11 | 2022-03-22 | English | Compare |
| v10 | 2022-03-22 | English | Compare |
| v9 | 2022-03-15 | French | Compare |
| v8 | 2022-03-15 | English | Compare |
| v7 | 2022-03-07 | French | Compare |
| v6 | 2022-03-07 | English | Compare |
| v5 | 2022-01-17 | French | Compare |
| v4 | 2022-01-17 | English | Compare |
| v3 | 2021-12-24 | English | Compare |
| v2 | 2021-12-13 | French | Compare |
| v1 | 2021-12-13 | English | Compare |
Showing 1 to 17 of 17